Merus NV
NASDAQ:MRUS

Watchlist Manager
Merus NV Logo
Merus NV
NASDAQ:MRUS
Watchlist
Price: 43.91 USD -2.47% Market Closed
Updated: May 18, 2024

Merus NV
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Merus NV
Operating Expenses Peer Comparison

Comparables:
PHARM
PRQR
QURE
ARGX
N
NAMS

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Merus NV
NASDAQ:MRUS
Operating Expenses
-$204.9m
CAGR 3-Years
-23%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Pharming Group NV
AEX:PHARM
Operating Expenses
-$241.9m
CAGR 3-Years
-29%
CAGR 5-Years
-25%
CAGR 10-Years
-34%
ProQR Therapeutics NV
NASDAQ:PRQR
Operating Expenses
-€44m
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Uniqure NV
NASDAQ:QURE
Operating Expenses
-$261.5m
CAGR 3-Years
-15%
CAGR 5-Years
-20%
CAGR 10-Years
-21%
argenx SE
XBRU:ARGX
Operating Expenses
-$1.5B
CAGR 3-Years
-43%
CAGR 5-Years
-68%
CAGR 10-Years
N/A
N
NewAmsterdam Pharma Company NV
NASDAQ:NAMS
Operating Expenses
-€101.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Merus NV's Operating Expenses?
Operating Expenses
-204.9m USD

Based on the financial report for Mar 31, 2024, Merus NV's Operating Expenses amounts to -204.9m USD.

What is Merus NV's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-22%

Over the last year, the Operating Expenses growth was 4%. The average annual Operating Expenses growth rates for Merus NV have been -23% over the past three years , -22% over the past five years .